Sterling Capital Management’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
Sterling Capital Management's CABA Position: Q3 2026 in Review
Sterling Capital Management increased its Cabaletta Bio (CABA) stake by 229% in Q3 2026, buying an estimated $8.52K and bringing the position to 4,342 shares worth $8.34K. The position accounts for ﹤0.01% of the portfolio, ranked #2610.
Sterling Capital Management first reported a position in CABA in Q3 2024 and has held it in 5 quarters since. 161 funds tracked by Wall St. Rank hold CABA as of Q3 2026.
- Sterling Capital Management held 4,342 shares of Cabaletta Bio worth $8.34K as of Q3 2026.
- Sterling Capital Management bought 3,023 Cabaletta Bio shares in Q3 2026, an estimated $8.52K.
- Cabaletta Bio made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2610 holding.
- Sterling Capital Management first reported a position in Cabaletta Bio in Q3 2024 and has held it in 5 quarters since.
- 161 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.